{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:24Z","timestamp":1792791564047,"version":"4.5.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111179","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:08:34Z","timestamp":1788480514000},"page":"111179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the AMPK\/SIRT1-NLRP3 inflammasome axis: Simvastatin, Ezetimibe, and their combination attenuate 3-nitropropionic acid-induced striatal neurodegeneration in rats"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1607-9888","authenticated-orcid":false,"given":"Abobakr M.","family":"Rezqallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-9002","authenticated-orcid":false,"given":"Shahira","family":"Nofal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111179_bib1","doi-asserted-by":"crossref","first-page":"27159","DOI":"10.1074\/jbc.M114.567537","article-title":"Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia","volume":"289","author":"Abais","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111179_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-019-00086-y","article-title":"Rutin and selenium co-administration reverse 3-nitropropionic acid-induced neurochemical and molecular impairments in a mouse model of Huntington's disease","volume":"37","author":"Abdelfattah","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2026.111179_bib3","article-title":"Nanocarrier-enhanced simvastatin modulates AMPK-ULK1 pathway and oxidative stress in alzheimer's disease model","author":"Afify","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10753-024-02019-0","article-title":"Sinapic acid mitigates pentylenetetrazol-induced acute seizures by modulating the nlrp3 inflammasome and regulating calcium\/calcineurin signaling: in vivo and in silico approaches","volume":"47","author":"Ali","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2026.111179_bib5","doi-asserted-by":"crossref","first-page":"15108","DOI":"10.1007\/s12035-025-05113-y","article-title":"Targeting of the PI3 K\/AKT\/GSK3\u03b2 pathway in parkinson's disease: a therapeutic blueprint","volume":"62","author":"AlRuwaili","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10787-022-00956-6","article-title":"Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK\/SIRT1 signaling and NLRP3 inflammasome","volume":"30","author":"Ammar","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111179_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1572657","article-title":"Striatal function scrutinized through the PAN-TAN-FSI triumvirate","volume":"19","author":"Apicella","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104220","article-title":"Simvastatin attenuates aluminium chloride-induced neurobehavioral impairments through activation of TGF-\u03b21\/SMAD2 and GSK3\u03b2\/\u03b2-catenin signalling pathways","volume":"102","author":"Atef","year":"2023","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib9","first-page":"120","article-title":"AMPK signaling pathway as a potential therapeutic target for Parkinson's disease","volume":"14","author":"Athari","year":"2023","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.neuropharm.2026.111179_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.608026","article-title":"Mitochondrial dysfunction in astrocytes: a role in Parkinson's disease?","volume":"8","author":"Bantle","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1317125","article-title":"Established and emerging techniques for the study of microglia: visualization, depletion, and fate mapping","volume":"18","author":"Bobotis","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4062\/biomolther.2026.026","article-title":"Simvastatin protects the dopaminergic neurons from MPTP-mediated injury by inducing BDNF via PPAR\u03b1 activation","volume":"34","author":"Bohara","year":"2026","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.neuropharm.2026.111179_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111179_bib15","first-page":"1","article-title":"Simvastatin rescues cognitive impairment in an A\u03b21-42-induced model of Alzheimer's disease through the HDAC2-BDNF signaling pathway","author":"Cai","year":"2026","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111179_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","article-title":"Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle","volume":"11","author":"Cant\u00f3","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2026.111179_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106672","article-title":"Metabolic dysregulation in Huntington's disease: neuronal and glial perspectives","volume":"201","author":"Chang","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70657","article-title":"AMPK\/SIRT1\/PGC\u20101\u03b1 signaling pathway: molecular mechanisms and targeted strategies from energy homeostasis regulation to disease therapy","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.111179_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-022-02419-9","article-title":"A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111179_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/WNR.0000000000001950","article-title":"Curcumin protects from LPS-induced activation of astrocytes via AMPK pathway","volume":"34","author":"Cheng","year":"2023","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2026.111179_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3892\/ijmm.2014.1747","article-title":"Geldanamycin attenuates 3-nitropropionic acid-induced apoptosis and JNK activation through the expression of HSP 70 in striatal cells","volume":"34","author":"Choi","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111179_bib23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/antiox14060696","article-title":"Oxidative stress: pathological driver in chronic neurodegenerative diseases","volume":"14","author":"Chong","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2026.111179_bib24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12975-019-00750-7","article-title":"Statin therapy in ischemic stroke models: a meta-analysis","volume":"11","author":"Christophe","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuropharm.2026.111179_bib25","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/mdc3.70152","article-title":"VAC14 variants identified in a patient with striatonigral degeneration and prolonged survival","volume":"12","author":"Cuinat","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2026.111179_bib26","series-title":"Handbook of Histopathological and Histochemical Techniques: including Museum Techniques","author":"Culling","year":"2013"},{"key":"10.1016\/j.neuropharm.2026.111179_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0253-7613.59925","article-title":"Potential of ezetimibe in memory deficits associated with dementia of Alzheimer' s type in mice","volume":"41","author":"Dalla","year":"2009","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","article-title":"Targeting AMPK by statins: a potential therapeutic approach","volume":"81","author":"Dehnavi","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2026.111179_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41582-025-01159-7","article-title":"Huntington disease: somatic expansion, pathobiology and therapeutics","volume":"22","author":"Donaldson","year":"2026","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12035-026-05967-w","article-title":"3-Nitropropionic acid\u2013induced huntington's disease in preclinical models: mechanisms, peripheral toxicities, model gaps, and future directions","volume":"63","author":"Dontiboina","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/ijmm.2014.1740","article-title":"Simvastatin attenuates TNF-\u03b1-induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1","volume":"34","author":"Du","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111179_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000513678","article-title":"Simvastatin prevents neurodegeneration in the MPTP mouse model of Parkinson's disease via inhibition of A1 reactive astrocytes","volume":"28","author":"Du","year":"2021","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2026.111179_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115750","article-title":"Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: a recent update from 2019 to mid-2023","volume":"260","author":"Duan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111179_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118076","article-title":"Dapagliflozin improves behavioral dysfunction of huntington's disease in rats via inhibiting apoptosis-related glycolysis","volume":"257","author":"El-Sahar","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120569","article-title":"Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR\/BDNF\/TrKB\/ERK\/CREB signaling pathway","volume":"300","author":"El-Shamarka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s10020-025-01172-y","article-title":"Neuroprotective role of morin hydrate on 3-nitropropionic acid-elicited Huntington'S disease: in vivo investigation of RIPK1\/RIPK3\/MLKL necroptosis signaling pathway","volume":"31","author":"Elbaz","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111179_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112640","article-title":"Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson's disease model in rats: role of AMPK\/SIRT-1\/PGC-1\u03b1 signaling and autophagy","volume":"138","author":"Elesawy","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/11795735221092517","article-title":"Current and possible future therapeutic options for Huntington's disease","volume":"14","author":"Ferguson","year":"2022","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111179_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/260161","article-title":"Neuroprotective effect of simvastatin via inducing the autophagy on spinal cord injury in the rat model","volume":"2015","author":"Gao","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.neuropharm.2026.111179_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121317","article-title":"Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1\/TLR4\/NF-\u03baB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats","volume":"314","author":"Gendy","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib42","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","article-title":"Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of parkinson's disease","volume":"29","author":"Ghosh","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114940","article-title":"Simvastatin exerts neuroprotective effects post-stroke by ameliorating endoplasmic reticulum stress and regulating autophagy\/apoptosis balance through pAMPK\/LC3B\/LAMP2 axis","volume":"381","author":"Ghosh","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/antiox14010070","article-title":"Unraveling the AMPK-SIRT1-FOXO pathway: the In-Depth analysis and breakthrough prospects of oxidative stress-induced diseases","volume":"14","author":"Guan","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2026.111179_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.07.001","article-title":"Endothelial function in high-risk patients with ezetimibe therapy","author":"G\u00fcnes-Altan","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110672","article-title":"Methylene blue attenuates 3-Nitropropionic acid-induced oxidative stress and mitochondrial dysfunction in striatal cells: therapeutic implications in huntington's disease neuropathology","volume":"26","author":"Hale","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122445","article-title":"Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2\/HO-1 signaling and attenuating oxidative stress and inflammation in rats","volume":"340","author":"Hasan","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib48","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1002\/jcp.30366","article-title":"Role of pyroptosis in atherosclerosis and its therapeutic implications","volume":"236","author":"He","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jgr.2021.11.003","article-title":"Ginsenoside compound K reduces the progression of huntington's disease via the inhibition of oxidative stress and overactivation of the ATM\/AMPK pathway","volume":"46","author":"Hua","year":"2022","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.neuropharm.2026.111179_bib50","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s10787-022-01004-z","article-title":"Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1\/Nrf2 signaling pathway","volume":"30","author":"Ibrahim","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111179_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1632773","article-title":"The burden of neurological diseases in G7 countries from 1990 to 2021 and projections for the next 30 years: a global burden of disease study","volume":"13","author":"Ji","year":"2026","journal-title":"Front. Public Health"},{"key":"10.1016\/j.neuropharm.2026.111179_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241613021","article-title":"From pathogenesis to therapeutics: a review of 150 years of Huntington's disease research","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6782872","article-title":"The beneficial roles of SIRT1 in neuroinflammation\u2010related diseases","volume":"2020","author":"Jiao","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2026.111179_bib54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150782","article-title":"Dose-dependent neuroprotection and neurotoxicity of simvastatin through reduction of farnesyl pyrophosphate in mice treated with intracerebroventricular injection of A\u03b2 1-42","volume":"50","author":"Jin","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114515","article-title":"Quercetin activates the Sestrin2\/AMPK\/SIRT1 axis to improve amyotrophic lateral sclerosis","volume":"161","author":"Jin","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111179_bib56","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1007\/s00210-024-03625-3","article-title":"Harnessing network pharmacology in drug discovery: an integrated approach","volume":"398","author":"Joshi","year":"2025","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13623","article-title":"Amyloid\u2010\u03b2 activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk\u2010AMPK pathway","volume":"21","author":"Jung","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2026.111179_bib58","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11064-014-1391-2","article-title":"Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity","volume":"40","author":"Karki","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.111179_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-024-01255-x","article-title":"Do statins affect cognitive health? A narrative review and critical analysis of the evidence","volume":"27","author":"Kazibwe","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.neuropharm.2026.111179_bib60","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1080\/15548627.2017.1356977","article-title":"Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition","volume":"13","author":"Kim","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2026.111179_bib61","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.37807","article-title":"Simvastatin inhibits cysteine\u2010rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin\u20101\/FoxO3a signaling","volume":"65","author":"Kok","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2026.111179_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1227\/01.NEU.0000346272.76537.DC","article-title":"Simvastatin attenuates microglia, astrocyte activation and decreases IL-1\u03b2 level following traumatic brain injury","volume":"65","author":"Li","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuropharm.2026.111179_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2024.12.011","article-title":"Beyond redox regulation: novel roles of TXNIP in the pathogenesis and therapeutic targeting of kidney disease","author":"Li","year":"2025","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib64","article-title":"Sirtuin1 in spinal cord injury: regulatory mechanisms, microenvironment remodeling and therapeutic potential","volume":"31","author":"Li","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.111179_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molimm.2018.10.001","article-title":"Periodontal ligament fibroblasts migration injury via ROS\/TXNIP\/Nlrp3 inflammasome pathway with Porphyromonas gingivalis lipopolysaccharide","volume":"103","author":"Lian","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib66","first-page":"105","article-title":"Simvastatin and simvastatin-ezetimibe improve the neurological function and attenuate the endothelial inflammatory response after spinal cord injury in rat","volume":"49","author":"Liang","year":"2019","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib67","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1007\/s12035-023-03371-2","article-title":"The effect of simvastatin on the dynamics of NF-\u03baB-regulated neurodegenerative and neuroprotective processes in the acute phase of ischemic stroke","volume":"60","author":"Lietzau","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib68","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mdc3.70335","article-title":"Early onset dystonia, parkinsonism, and spasticity in siblings with VAC14\u2010Associated neurodegeneration: a case report and literature review","volume":"13","author":"Lindsay","year":"2026","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2026.111179_bib69","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/biomedicines10061250","article-title":"NF-\u03baB: a double-edged sword controlling inflammation","volume":"10","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2026.111179_bib70","article-title":"Neurotransmitter receptors on microglia","volume":"1","author":"Liu","year":"2016","journal-title":"Strok. Vasc. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib71","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s10020-024-01025-0","article-title":"The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood\u2013brain barrier protection","volume":"30","author":"Liu","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111179_bib72","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3390\/ijms21103609","article-title":"Early reactive A1 astrocytes induction by the neurotoxin 3-nitropropionic acid in rat brain","volume":"21","author":"Lopez-Sanchez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib73","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/hmg\/ddaa196","article-title":"Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out","volume":"29","author":"Loupe","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2026.111179_bib74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11883-025-01386-9","article-title":"Pleiotropic effects of statins: focus on inflammation, oxidative stress and immunomodulation (Part I)","volume":"28","author":"Mahmoudi","year":"2026","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.neuropharm.2026.111179_bib75","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41419-023-05977-9","article-title":"Statins suppress cell-to-cell propagation of \u03b1-synuclein by lowering cholesterol","volume":"14","author":"Min","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib76","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jpp\/rgad013","article-title":"Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt\/NF-\u03baB\/STAT3\/CXCL10 signaling axis","volume":"75","author":"Mostafa","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11064-015-1739-2","article-title":"Characteristic changes of astrocyte and microglia in rat striatum induced by 3-NP and MCAO","volume":"41","author":"Mu","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.111179_bib78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathmechdis-051122-104528","article-title":"Multiple system atrophy: pathology, pathogenesis, and path forward","volume":"20","author":"Ndayisaba","year":"2025","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11883-025-01280-4","article-title":"Achieving more optimal lipid control with Non-statin lipid lowering therapy","volume":"27","author":"Nicholls","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.neuropharm.2026.111179_bib80","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10020-024-00917-5","article-title":"Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting","volume":"30","author":"Noureldeen","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111179_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813992","article-title":"Ezetimibe induces vasodilation in rat mesenteric resistance arteries through inhibition of extracellular Ca2+ influx","volume":"24","author":"Oh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib82","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.3390\/ijms26136220","article-title":"Update on the symptomatic treatment of huntington's disease: from pathophysiology to clinical practice","volume":"26","author":"Olmedo-Saura","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib83","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms23158363","article-title":"Emerging role of NLRP3 inflammasome\/pyroptosis in Huntington's disease","volume":"23","author":"Paldino","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102157","article-title":"Reactive oxygen species trigger NF-\u03baB-mediated NLRP3 inflammasome activation involvement in low-dose CdTe QDs exposure-induced hepatotoxicity","volume":"47","author":"Pang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102255","article-title":"Unveiling the interplay of AMPK\/SIRT1\/PGC-1\u03b1 axis in brain health: promising targets against aging and NDDs","author":"Rakshe","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.111179_bib86","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221111440","article-title":"Simvastatin cardioprotection in cyclophosphamide-induced toxicity via the modulation of inflammasome\/caspase1\/interleukin1\u03b2 pathway","volume":"41","author":"Refaie","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310414","article-title":"Repurposing simvastatin in Parkinson's disease model: protection is throughout modulation of the neuro-inflammatory response in the substantia nigra","volume":"24","author":"Rubio-Osornio","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib88","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: a long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2026.111179_bib89","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","article-title":"Neuroinflammation in Huntington's disease: a starring role for astrocyte and microglia","volume":"20","author":"Saba","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib90","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12974-024-03296-0","article-title":"Fueling neurodegeneration: metabolic insights into microglia functions","volume":"21","author":"Sadeghdoust","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111179_bib91","article-title":"Simvastatin-induced neuroprotective effect after brain injury is mediated by mitochondrial protection through modulation of the 18 kDa translocator protein","volume":"e00803","author":"Sakas","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.111179_bib92","first-page":"1","article-title":"HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer\u2019s-associated markers","volume":"40","author":"Salari","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuro.2026.103405","article-title":"Microglia as a key mediator in rosuvastatin-associated cognitive impairment","volume":"113","author":"Sang","year":"2026","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2026.111179_bib94","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","article-title":"Vildagliptin attenuates huntington's disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model","volume":"17","author":"Sayed","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.111179_bib95","series-title":"Iron Metabolism in Human Health and Disease","first-page":"291","article-title":"Neurodegeneration with brain iron accumulation","author":"Schipper","year":"2025"},{"key":"10.1016\/j.neuropharm.2026.111179_bib96","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","article-title":"Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors","volume":"118","author":"Shalaby","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293660","article-title":"Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease","volume":"18","author":"Shehata","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111179_bib98","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","article-title":"Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach","volume":"18","author":"Singh","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s42255-025-01442-3","article-title":"AMPK at the interface of nutrient sensing, metabolic flux and energy homeostasis","volume":"8","author":"Smith","year":"2026","journal-title":"Nat. Metab."},{"key":"10.1016\/j.neuropharm.2026.111179_bib100","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2995602","article-title":"Ezetimibe improves rosuvastatin effects on inflammation and vascular endothelial function in acute coronary syndrome patients undergoing PCI","volume":"2021","author":"Sun","year":"2021","journal-title":"J. Intervent. Cardiol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1465849","article-title":"The relationship between SIRT1 and inflammation: a systematic review and meta-analysis","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106554","article-title":"Microglial proliferation and astrocytic protein alterations in the human huntington's disease cortex","volume":"198","author":"Tan","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib103","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/cells14241966","article-title":"Pathological and molecular insights into the early stage of multiple system atrophy","volume":"14","author":"Tanaka","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111179_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fnmol.2018.00165","article-title":"Simvastatin inhibits activation of NADPH oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in parkinson disease models","volume":"11","author":"Tong","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future","volume":"15","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111179_bib106","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s11064-023-03868-1","article-title":"An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a Huntington'S disease model and its relevance to drug discovery and development","volume":"48","author":"Upadhayay","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.111179_bib107","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0306-4522(00)00500-5","article-title":"No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy)","volume":"102","author":"Waldner","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111179_bib108","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/fcp.12635","article-title":"Simvastatin\u2013ezetimibe enhances growth factor expression and attenuates neuron loss in the hippocampus in a model of intracerebral hemorrhage","volume":"35","author":"Wang","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib109","first-page":"2937","article-title":"The expanding burden of neurodegenerative diseases: an unmet medical and social need","volume":"16","author":"Wang","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib110","article-title":"Simvastatin inhibits NLRP3 inflammasome activation and ameliorates lung injury in hyperoxia\u2010induced bronchopulmonary dysplasia via the KLF2\u2010Mediated mechanism","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2026.111179_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104640","article-title":"Nurr1 modulation mediates neuroprotective effects of statins","volume":"9","author":"Willems","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neuropharm.2026.111179_bib112","first-page":"1","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","author":"Xu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib114","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cns.12053","article-title":"Simvastatin induces neuroprotection in 6\u2010OHDA\u2010Lesioned PC 12 via the PI 3K\/AKT\/Caspase 3 pathway and anti\u2010inflammatory responses","volume":"19","author":"Xu","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.111179_bib115","article-title":"TXNIP\/NLRP3 aggravates global cerebral ischemia-reperfusion injury-induced cognitive decline in mice","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2026.111179_bib116","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells14040276","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"14","author":"Yang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111179_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fceld.2024.1503799","article-title":"Regulation of pyroptosis by NF-\u03baB signaling","volume":"3","author":"Yang","year":"2025","journal-title":"Front. Cell Death"},{"key":"10.1016\/j.neuropharm.2026.111179_bib118","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4717258","article-title":"Ezetimibe attenuates oxidative stress and neuroinflammation via the AMPK\/Nrf2\/TXNIP pathway after MCAO in rats","volume":"2020","author":"Yu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2026.111179_bib119","doi-asserted-by":"crossref","first-page":"15390","DOI":"10.1007\/s12035-025-05162-3","article-title":"Multiple mechanisms and therapeutic strategies for the involvement of AMPK in the development of alzheimer's disease","volume":"62","author":"Yu","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s44324-025-00067-0","article-title":"The role of NAD+ metabolism and its modulation of mitochondria in aging and disease","volume":"3","author":"Yusri","year":"2025","journal-title":"npj Metabol. Health Dis."},{"key":"10.1016\/j.neuropharm.2026.111179_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114611","article-title":"Simvastatin improves learning and memory impairment via gut-brain axis regulation in an ovariectomized\/D-galactose Alzheimer's rat model","volume":"453","author":"Zahedi","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111179_bib122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13020-024-01056-z","article-title":"Network pharmacology: a crucial approach in traditional Chinese medicine research","volume":"20","author":"Zhai","year":"2025","journal-title":"Chin. Med."},{"key":"10.1016\/j.neuropharm.2026.111179_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1405546","article-title":"SIRT1 exerts protective effects by inhibiting endoplasmic reticulum stress and NF-\u03baB signaling pathways","volume":"12","author":"Zhao","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.111179_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156677","article-title":"The ROS\/TXNIP\/NLRP3 pathway mediates LPS-induced microglial inflammatory response","volume":"181","author":"Zhao","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2026.111179_bib125","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/biom14101204","article-title":"Astrocyte-mediated neuroinflammation in neurological conditions","volume":"14","author":"Zhao","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.111179_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1412997","article-title":"Application of network pharmacology in traditional Chinese medicine for the treatment of digestive system diseases","volume":"15","author":"Zheng","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:57:03Z","timestamp":1792789023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":125,"alternative-id":["S0028390826003540"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111179","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the AMPK\/SIRT1-NLRP3 inflammasome axis: Simvastatin, Ezetimibe, and their combination attenuate 3-nitropropionic acid-induced striatal neurodegeneration in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111179"}}